Omeicos Opthalmics is a German-owned, USA-based firm founded in 2017 dedicated to finding treatments for optical conditions.

As of April 2018, Omeicos is led by chairman and CEO Alexander Gebauer. Gebauer also serves on the board of Omeicos' parent company, Omeicos Therapeutics.